Eps Summary of Genus plc

Genus plc's latest annual eps in 2024 was 0.12 USD , down -81.25% from previous year.
Genus plc's latest quarterly eps in 2024 FY was N/A , down -76.56% from previous quarter.
Genus plc reported an annual eps of 0.64 USD in 2023, down -15.79% from previous year.
Genus plc reported an annual eps of 0.76 USD in 2022, down -24.0% from previous year.
Genus plc reported a quarterly eps of 0.26 USD for 2024 Q2, up 160.0% from previous quarter.
Genus plc reported a quarterly eps of N/A for 2024 FY, down -76.56% from previous quarter.

Annual Eps Chart of Genus plc (2024 - 1996)

Historical Annual Eps of Genus plc (2024 - 1996)

Year	Eps	Eps Growth
2024	0.12 USD	-81.25%
2023	0.64 USD	-15.79%
2022	0.76 USD	-24.0%
2021	1.00 USD	49.25%
2020	0.67 USD	458.33%
2019	0.12 USD	-82.86%
2018	0.70 GBP	0.0%
2017	0.70 GBP	-35.19%
2016	1.08 GBP	61.19%
2015	0.67 GBP	39.58%
2014	0.48 GBP	6.67%
2013	0.45 GBP	-31.82%
2012	0.66 GBP	34.69%
2011	0.49 GBP	6.52%
2010	0.46 GBP	53.33%
2009	0.30 GBP	-3.23%
2008	0.31 GBP	14.81%
2007	0.27 GBP	58.82%
2006	0.17 GBP	6.25%
2005	0.16 GBP	0.0%
2004	0.16 GBP	92.77%
2003	0.08 GBP	388.24%
2002	0.02 GBP	-63.83%
2001	0.05 GBP	-57.27%
2000	0.11 GBP	-8.33%
1999	0.12 GBP	22.45%
1998	0.10 GBP	-51.0%
1997	0.20 GBP	5.26%
1996	0.19 GBP	0.0%

Year	Eps	Eps Growth
2024 Q1	0.10 GBP	-74.36%
2024 Q2	0.26 USD	160.0%
2024 FY	- USD	-76.56%
2024 Q4	-0.11 USD	0.0%
2023 Q2	0.25 USD	150.0%
2023 Q1	0.10 GBP	-37.5%
2023 Q3	0.15 GBP	-40.0%
2023 Q4	0.39 USD	160.0%
2023 FY	- USD	-15.79%
2022 Q1	0.15 GBP	15.38%
2022 FY	- USD	-24.0%
2022 Q3	0.16 GBP	6.67%
2022 Q2	0.15 USD	0.0%
2022 Q4	0.16 USD	0.0%
2021 FY	- USD	49.25%
2021 Q2	0.23 USD	0.0%
2021 Q1	0.23 GBP	159.59%
2021 Q4	0.13 USD	0.0%
2021 Q3	0.13 GBP	-43.48%
2020 Q2	0.18 USD	0.0%
2020 Q4	0.09 USD	0.0%
2020 FY	- USD	458.33%
2020 Q1	0.18 GBP	63.64%
2020 Q3	0.09 GBP	-50.78%
2019 Q1	-0.06 GBP	-1369.57%
2019 Q3	0.11 GBP	288.36%
2019 FY	- USD	-82.86%
2019 Q4	0.11 USD	0.0%
2019 Q2	-0.06 GBP	0.0%
2018 Q1	0.34 GBP	70.0%
2018 Q2	0.34 GBP	0.0%
2018 FY	- GBP	0.0%
2018 Q3	0.00 GBP	-98.65%
2018 Q4	0.00 GBP	0.0%
2017 Q4	0.20 GBP	0.0%
2017 FY	- GBP	-35.19%
2017 Q1	0.07 GBP	-79.53%
2017 Q2	0.07 GBP	0.0%
2017 Q3	0.20 GBP	205.34%
2016 FY	- GBP	61.19%
2016 Q4	0.32 GBP	0.0%
2016 Q3	0.32 GBP	272.09%
2016 Q2	0.09 GBP	0.0%
2016 Q1	0.09 GBP	-46.25%
2015 FY	- GBP	39.58%
2015 Q3	0.16 GBP	0.0%
2015 Q1	0.16 GBP	65.98%
2015 Q2	0.16 GBP	0.0%
2015 Q4	0.16 GBP	0.0%
2014 Q4	0.10 GBP	0.0%
2014 FY	- GBP	6.67%
2014 Q3	0.10 GBP	-31.14%
2014 Q2	0.14 GBP	0.0%
2014 Q1	0.14 GBP	115.38%
2013 Q2	- GBP	0.0%
2013 FY	- GBP	-31.82%
2013 Q4	0.06 GBP	0.0%
2013 Q3	0.06 GBP	0.0%
2012 Q2	- GBP	0.0%
2012 FY	- GBP	34.69%
2011 FY	- GBP	6.52%
2011 Q2	- GBP	0.0%
2010 FY	- GBP	53.33%
2010 Q2	- GBP	0.0%
2009 FY	- GBP	-3.23%
2009 Q2	- GBP	0.0%
2008 Q2	- GBP	0.0%
2008 FY	- GBP	14.81%
2007 Q2	- GBP	0.0%
2007 FY	- GBP	58.82%
2006 FY	- GBP	6.25%
2006 Q1	- GBP	0.0%
2005 FY	- GBP	0.0%
2005 Q1	- GBP	0.0%
2004 Q1	- GBP	0.0%
2004 FY	- GBP	92.77%
2003 FY	- GBP	388.24%
2002 FY	- GBP	-63.83%
2001 FY	- GBP	-57.27%
2000 FY	- GBP	-8.33%
1999 FY	- GBP	22.45%
1998 FY	- GBP	-51.0%
1997 FY	- GBP	5.26%
1996 FY	- GBP	0.0%

Peer Eps Comparison of Genus plc

Name	Eps	Eps Difference
Burzynski Research Institute, Inc.	-0.01 USD	1276.471%
Arch Therapeutics, Inc.	-2.27 USD	105.286%
Evofem Biosciences, Inc.	10.35 USD	98.841%
Nascent Biotech, Inc.	-0.01 USD	995.522%
Rebus Holdings, Inc.	-0.03 USD	473.832%
Santhera Pharmaceuticals Holding AG	5.95 USD	97.983%
Qrons Inc.	-0.06 USD	305.832%
Adynxx, Inc.	- USD	-Infinity%
Neon Bloom, Inc.	-0.00 USD	8100.0%
Northwest Biotherapeutics, Inc.	-0.06 USD	308.696%
ProtoKinetix, Incorporated	-0.01 USD	1300.0%
Skye Bioscience, Inc.	-5.37 USD	102.235%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	100.236%
Nanobac Pharmaceuticals, Incorporated	- USD	-Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	333.01%
SQZ Biotechnologies Company	-2.76 USD	104.348%
Intellipharmaceutics International Inc.	-0.09 USD	237.3%
Propanc Biopharma, Inc.	-0.02 USD	606.329%
Mesoblast Limited	-0.09 USD	234.68%
Marizyme, Inc.	-1.44 USD	108.333%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	105.15%
Pharming Group N.V.	-0.02 USD	845.342%
Therapeutic Solutions International, Inc.	-0.00 USD	17242.857%
CNBX Pharmaceuticals Inc.	-0.42 USD	128.571%
Nymox Pharmaceutical Corporation	-0.10 USD	224.352%
ContraFect Corporation	-124.97 USD	100.096%
PsyBio Therapeutics Corp.	-0.04 USD	385.714%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	1100.0%
IMV Inc.	-4.37 USD	102.746%
AXIM Biotechnologies, Inc.	-0.04 USD	438.983%
MultiCell Technologies, Inc.	-0.00 USD	120100.0%
ONE Bio Corp.	1.43 USD	91.608%
Accustem Sciences Inc.	-0.34 USD	135.294%
RVL Pharmaceuticals plc	-0.58 USD	120.69%
Arno Therapeutics, Inc.	- USD	-Infinity%
EV Biologics, Inc.	-0.12 USD	200.0%
Q BioMed Inc.	-0.08 USD	253.649%
Emmaus Life Sciences, Inc.	-0.07 USD	270.697%
Mosaic ImmunoEngineering Inc.	-0.33 USD	136.364%
Biomind Labs Inc.	-0.02 USD	840.741%
American Oriental Bioengineering, Inc.	-781.24 USD	100.015%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	1721.622%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Oncotelic Therapeutics, Inc.	-0.02 USD	703.015%
GlobeStar Therapeutics Corporation	-0.00 USD	5100.0%
THC Farmaceuticals, Inc.	-0.00 USD	15100.0%
Acro Biomedical Co., Ltd.	-0.26 USD	146.154%
Curative Biotechnology, Inc.	-0.01 USD	1463.636%
GB Sciences, Inc.	-0.00 USD	3026.829%
Alpha Cognition Inc.	-0.15 USD	180.0%
HST Global, Inc.	-0.03 USD	530.108%
CSL Limited	2.73 USD	95.604%
Wesana Health Holdings Inc.	-0.05 USD	339.521%
Halberd Corporation	-0.00 USD	120100.0%
Enzolytics Inc.	-0.00 USD	17242.857%
Agentix Corp.	-0.04 USD	442.857%
Resverlogix Corp.	-0.01 USD	945.07%
Nuo Therapeutics, Inc.	-0.08 USD	259.151%
MetaStat, Inc.	- USD	-Infinity%
argenx SE	-5.16 USD	102.326%
Enzon Pharmaceuticals, Inc.	0.00 USD	-9130.769%
Endonovo Therapeutics, Inc.	0.03 USD	-378.088%
RespireRx Pharmaceuticals Inc.	-0.04 USD	436.134%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	-0.02 USD	700.0%
AVAX Technologies, Inc.	-0.05 USD	322.635%
Zenith Capital Corp.	-0.07 USD	271.674%
Genscript Biotech Corporation	-0.05 USD	364.317%
Ember Therapeutics, Inc.	-0.01 USD	2004.762%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	103.183%
WPD Pharmaceuticals Inc.	-0.00 USD	24100.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	231.435%
Kadimastem Ltd	-0.78 USD	115.385%
Helix BioMedix, Inc.	-4.70 USD	102.553%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	-36.39 USD	100.33%
BioStem Technologies, Inc.	-0.62 USD	119.355%
Oncology Pharma Inc.	- USD	-Infinity%
Reve Technologies, Inc.	-0.01 USD	1108.403%
LadRx Corporation	0.68 USD	82.353%
Cell Source, Inc.	-0.17 USD	170.588%
Regen BioPharma, Inc.	0.29 USD	58.621%
Regen BioPharma, Inc.	0.26 USD	53.846%
NovAccess Global Inc.	-0.23 USD	152.174%
Affymax, Inc.	-0.39 USD	130.769%
Itoco Inc.	-0.01 USD	1678.947%
Rasna Therapeutics, Inc.	-0.01 USD	1300.0%
Pathfinder Cell Therapy, Inc.	-0.00 USD	4900.0%
Mobile Lads Corp.	-0.01 USD	2242.857%
CytoDyn Inc.	-0.05 USD	326.843%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	24100.0%
NanoSphere Health Sciences Inc.	-0.02 USD	640.541%
Alseres Pharmaceuticals, Inc.	-153.67 USD	100.078%
SYBLEU INC	-0.02 USD	785.714%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	945.07%
International Stem Cell Corporation	-0.02 USD	831.707%
Bioxytran, Inc.	-0.03 USD	476.176%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	-0.00 USD	120100.0%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	-7.99 USD	101.502%
Adhera Therapeutics, Inc.	-1.18 USD	110.169%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	-0.03 USD	452.941%
Innovation Pharmaceuticals Inc.	-0.01 USD	2004.762%
Neutra Corp.	-0.00 USD	120100.0%
Windtree Therapeutics, Inc.	-94.23 USD	100.127%
PureTech Health plc	-2.38 USD	105.042%
Coeptis Therapeutics, Inc.	-0.83 USD	114.458%
IXICO plc	-0.02 USD	591.803%
IntelGenx Technologies Corp.	-0.06 USD	311.268%
Gelesis Holdings, Inc.	-1.35 USD	108.889%
CSL Limited	5.47 USD	97.806%
Cellectis S.A.	-1.77 USD	106.78%

Global Stocks Search

Genus plc (GENSF)

Eps Summary of Genus plc

Annual Eps Chart of Genus plc (2024 - 1996)

Historical Annual Eps of Genus plc (2024 - 1996)

Peer Eps Comparison of Genus plc